Texas Republican Rep. Tony Gonzales has come under fire for allegedly having a romantic relationship with a staffer who died ...

The Foundation for Angelman Syndrome Therapeutics (FAST) has helped redefine the role of advocacy groups. Founded and led by ...

The science behind rare disease treatments is advancing at an unprecedented pace. Biogen is sharpening its long-term strategy ...

Personalized therapies, faster diagnoses, and a renewed and previously unimaginable sense of hope for rare disease families.

As scientific and political pressures collide at the FDA, regulatory bottlenecks are intensifying. At this critical and ...

Sarepta has come under scrutiny over Elevidys, its gene therapy for Duchenne Muscular Dystrophy (DMD). With a one-time ...

Anthropic AI is growing rapidly in usage among companies, but with the Trump administration declaring economic war on the ...

Amazon said the Bahrain facility was damaged due to a nearby drone strike, and two data centers in the UAE were directly hit ...

Stocks rebounded on Wednesday, buoyed by gains in technology and semiconductor giants. Oil prices stabilized after this ...

CNBC’s Jim Cramer said the oil market may be signaling the war with Iran won’t escalate into a prolonged disruption to crude ...

Broadcom's AI revenue jumped 106% as the company continues to be a big beneficiary of the boom in infrastructure spending.

CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more. Got a confidential news tip? We want ...